|
⚲
|
| Keyboard |
| Bausch Christoph Lawrence
✚
|
|
|---|---|
| CIK # | 0001889981 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889981] | |
| 4 | [0001889981] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Bausch Christoph Lawrence |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Stock option (right to buy) · derivative
|
2026-02-03 | Grant | 1,800,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2024-02-21 | Grant | 140,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2023-03-14 | Grant | 275,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-09-13 | Grant | 274,875 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-03-16 | Grant | 24,972 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Restricted Stock Units) · derivative
|
2021-10-22 | Grant | 108,086 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 104,689 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 81,425 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 69,793 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 11,632 |